胱抑素C与慢性肾脏病儿童及青少年的心脏指标
研究纳入678例轻至中度慢性肾脏病(CKD)儿童及青少年,共1228次超声心动图测量,前瞻性评估血清胱抑素C与心脏结构及功能的关系。结果显示胱抑素C每升高1 mg/L与左心室质量指数升高及舒张功能指标改变独立相关,且校正实测肾小球滤过率(mGFR)后胱抑素C仍与E'/A'比值独立相关。
要点
- 胱抑素C每升高1 mg/L与左心室质量指数升高7.7%独立相关(95%CI 5.3%-10.0%)。
- 胱抑素C每升高1 mg/L与E'/A'比值降低6.6%独立相关(95%CI -9.0%至-4.2%)。
- 校正mGFR后胱抑素C仍与E'/A'比值独立相关,而mGFR不再独立相关。
核心结论
- 在轻至中度CKD儿童及青少年中,胱抑素C水平与心脏结构和舒张功能独立相关。
- 校正mGFR后胱抑素C仍能预测E'/A'比值所反映的舒张功能下降,提示胱抑素C可能在CKD儿童及青少年心血管疾病风险分层中具有独立作用。
研究设计与样本
- 前瞻性队列研究,纳入CKD in Children(CKiD)研究中678例轻至中度CKD儿童及青少年,共1228次超声心动图获得的心脏结构和功能测量。
主要发现
- 独立于时间,血清胱抑素C每升高1 mg/L与左心室质量指数同期升高7.7%(95%CI 5.3%-10.0%)独立相关。
- 胱抑素C每升高1 mg/L与E/A比值变化-4.7%(95%CI -7.0%至-2.4%)独立相关。
- 胱抑素C每升高1 mg/L与E'/A'比值变化-6.6%(95%CI -9.0%至-4.2%)独立相关。
- 胱抑素C每升高1 mg/L与E/E'比值升高2.5%(95%CI 0.3%-4.7%)独立相关。
- mGFR也与E'/A'比值独立相关;当胱抑素C与mGFR同时纳入模型时,胱抑素C仍与E'/A'比值独立相关,而mGFR不再独立相关。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 24%的队列缺失感兴趣结局或测量的数据。
- 研究人群仅包括轻至中度CKD儿童及青少年。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cardiovascular disease (CVD) is highly prevalent among children with chronic kidney disease (CKD). Cystatin C is an established marker of kidney function and an emerging biomarker for CVD events. We quantified the relationship between cystatin C level and cardiac structure and function over time among children with CKD and assessed whether cystatin C level and diastolic function retained an association after accounting for kidney function. STUDY DESIGN: Prospective cohort study. SETTING & PARTICIPANTS: 678 children and adolescents with mild to moderate CKD enrolled in the CKD in Children (CKiD) Study with 1,228 echocardiographically obtained cardiac structure and function measurements. PREDICTOR: Serum cystatin C (mg/L) measured annually. OUTCOMES: Cardiac structure (left ventricular mass index [g/m2.7]) and cardiac function (shortening fraction; E/A, E'/A', E/E' ratios) measured every other year. MEASUREMENTS: Demographics and anthropometrics, measured glomerular filtration rate (mGFR), heart rate, blood pressure, hemoglobin z score, serum albumin level, and calcium-phosphorus product. RESULTS: Independent of time, each 1-mg/L increase in cystatin C level was independently associated with a concurrent 7.7% (95% CI, 5.3%-10.0%) increase in left ventricular mass index, a -4.7% (95% CI, -7.0% to -2.4%) change in E/A ratio, a -6.6% (95% CI, -9.0% to -4.2%) change in E'/A' ratio, and a 2.5% (95% CI, 0.3%-4.7%) increase in E/E' ratio. mGFR was also independently associated with E'/A' ratio. When cystatin C level and mGFR were included in the same model, cystatin C level remained independently associated with E'/A' ratio, whereas mGFR was not. LIMITATIONS: 24% of the cohort was missing data for outcomes of interest or measurements; study population includes only children and adolescents with mild to moderate CKD. CONCLUSIONS: In this study of children and adolescents with mild to moderate CKD, cystatin C level was independently associated with cardiac structure and diastolic function. Cystatin C level remained able to predict diastolic function decline via E'/A' ratio even after adjusting for mGFR, suggesting that cystatin C level may have an independent role in CVD risk stratification among children and adolescents with CKD.
引用
- Brady TM, Townsend K, Schneider MF, et al. Cystatin C and Cardiac Measures in Children and Adolescents With CKD. Am J Kidney Dis. 2016. PMID: 27856090. doi:10.1053/j.ajkd.2016.08.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。